Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome

This publication has 25 references indexed in Scilit:

• Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein
  The American Journal of Cardiology, 2003
• Risk for Myopathy With Statin Therapy in High-Risk Patients
  Archives of internal medicine (1960), 2003
• American Heart Association Guide for Improving Cardiovascular Health at the Community Level
  Circulation, 2003
• C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
  Circulation, 2003
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
  Published by Elsevier ,2001
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
  Circulation, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
  JAMA, 1998